Preceptorship in colorectal cancer
The Australasian Gastro-Intestinal Trials Group (AGITG) presents a Preceptorship in colorectal cancer Convenor: A/Prof Eva Segelov Preceptors: A/Prof Joe McKendrick,... Read More
The Australasian Gastro-Intestinal Trials Group (AGITG) presents a Preceptorship in colorectal cancer Convenor: A/Prof Eva Segelov Preceptors: A/Prof Joe McKendrick,... Read More
Based at the Royal Melbourne Hospital, Professor Finlay Macrae is a clinical researcher whose major focus is the... Read More
Associate Professor Eva Segelov, Clinical Academic at the St Vincent’s Clinical School at UNSW and Medical Oncologist, shares... Read More
Colorectal cancer is one of the most common cancers in Australia and the second leading cause of cancer... Read More
His Honor Alan Bishop was a wonderful contributor to the AGITG and the GI Cancer Institute. In a... Read More
The AGITG 2013 Annual General Meeting (AGM) coincides with a meeting of the Scientific Advisory Committee and is... Read More
The 15th AGITG Annual Scientific Meeting will be held in Melbourne on 8-10 October 2013. The meeting will feature... Read More
A grant to fund the AGITG’s TOP GEAR trial for both phase II and phase III of the... Read More
At the 2012 AGITG Annual Scientific Meeting the GI Cancer Institute launched Engage: a free online information network... Read More
Over the past six months there have been a further six publications involving the group including: the survival... Read More
At a recent AGITG Board meeting in November, Associate Professor Tim Price was unanimously voted by the AGITG... Read More
Are Colorectal Cancer Trials Meeting Patient’s Needs? Colorectal cancer has the highest incidence of all cancers and is the... Read More
Irinotecan Cetuximab Evaluation and the Cetuximab Response Evaluation Among Mutants: A randomised Phase II study of cetuximab... Read More
6 – 8 September 2012 at the Sofitel Wentworth Sydney. Sessions included topics such as Refractory Colorectal Cancer;... Read More
Congratulations to the ‘Cancer can’t kill hope’ team that ran in the Sun-Herald Sydney City2Surf in August 2012.... Read More
Doctors have new treatments for advanced bowel cancer patients who are too ill to have chemotherapy. Professor John... Read More
Personalising cancer treatment for individuals is proving to be effective. Medical oncologist Professor Tim Price claims that by... Read More
By Anna Grummitt Mahmoud Chatila is an unstoppable 19-year-old from Melbourne who recently ran from Melbourne to Sydney in... Read More
Cancer Can’t Kill Hope – run for GI Cancer at this year’s City2Surf Running for the ‘Cancer can’t kill hope’ team in the Sydney City2Surf is a great way to keep healthy and help reduce your cancer risk – it also provides much needed funds for GI cancer trials. We... Read More